Feed EHC
EH

Encompass Health EHC · NYSE

$121.70 -4.83% (-$6.17)

Summary

77 / 100 · Bulios Score

What speaks for it

  • Earnings per share grew by 27% a year over the last 3 years.
  • It earns 13 USD a year on every 100 USD of invested capital.

What to watch

  • The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $121.7
5-year average P/E 18.8 3.0% higher
P/E today 19.3
Medical - Care Facilities industry median
P/E today 19.3

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 19.3 USD for 1 USD of yearly profit. Over the last five years it was 18.8 USD on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 11% a year. For the next fiscal year analysts expect revenue to grow by 8.8%.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Net profit, industry median (Medical - Care Facilities) 6.7 USD

Out of every 100 USD of revenue, 10 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 6.9 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Small, safe
Yield
0.64%
Paid out of profit
12%
Raised in a row
2 years

You receive $0.78 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $150.2 is 23% above today's price. 81% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

The company reports no revenue by region.

Inpatient brings in 97% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.